Susquehanna International Group, LLP 2seventy Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.85 - $5.05 $57,750 - $75,750
15,000 New
15,000 $70,000
Q1 2024

May 07, 2024
SELL
$3.09 - $6.0 $80,031 - $155,400
-25,900 Reduced 50.39%
25,500 $136,000
Q4 2023

Feb 14, 2024
BUY
$1.57 - $4.58 $80,698 - $235,412
51,400 New
51,400 $219,000
Q3 2022

Nov 14, 2022
SELL
$12.56 - $17.54 $74,104 - $103,486
-5,900 Reduced 13.47%
37,900 $551,000

Others Institutions Holding TSVT

# of Institutions
126
Shares Held
45.6M
Call Options Held
122K
Put Options Held
19.8K
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email